Cargando…

Extended coagulation profile of children with Long Covid: a prospective study

Emerging data suggests that endotheliopathy changes can be associated with post covid condition (PCC) in adults. Research on the matter in children is lacking. We analyzed an extended coagulation profile including biomarkers of endothelial damage in children with PCC and compared it with a control g...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Gennaro, Leonardo, Valentini, Piero, Sorrentino, Silvia, Ferretti, Maria Antonietta, De Candia, Erica, Basso, Maria, Lancellotti, Stefano, De Cristofaro, Raimondo, De Rose, Cristina, Mariani, Francesco, Morello, Rosa, Lazzareschi, Ilaria, Sigfrid, Louise, Munblit, Daniel, Buonsenso, Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626616/
https://www.ncbi.nlm.nih.gov/pubmed/36319840
http://dx.doi.org/10.1038/s41598-022-23168-y
_version_ 1784822775551098880
author Di Gennaro, Leonardo
Valentini, Piero
Sorrentino, Silvia
Ferretti, Maria Antonietta
De Candia, Erica
Basso, Maria
Lancellotti, Stefano
De Cristofaro, Raimondo
De Rose, Cristina
Mariani, Francesco
Morello, Rosa
Lazzareschi, Ilaria
Sigfrid, Louise
Munblit, Daniel
Buonsenso, Danilo
author_facet Di Gennaro, Leonardo
Valentini, Piero
Sorrentino, Silvia
Ferretti, Maria Antonietta
De Candia, Erica
Basso, Maria
Lancellotti, Stefano
De Cristofaro, Raimondo
De Rose, Cristina
Mariani, Francesco
Morello, Rosa
Lazzareschi, Ilaria
Sigfrid, Louise
Munblit, Daniel
Buonsenso, Danilo
author_sort Di Gennaro, Leonardo
collection PubMed
description Emerging data suggests that endotheliopathy changes can be associated with post covid condition (PCC) in adults. Research on the matter in children is lacking. We analyzed an extended coagulation profile including biomarkers of endothelial damage in children with PCC and compared it with a control group of children that fully recovered post- SARS-CoV-2 infection. A case-control study enrolling children below 18 years of age with previous microbiologically confirmed SARS-CoV-2 infection in a pediatric post-covid unit in Italy ≥ 8 weeks after the initial infection. Samples were taken at 8 and 12 weeks after the SARS-CoV-2 diagnosis and analyzed for coagulation profiling (fibrinogen, prothrombin time, international normalized ratio, activated partial thromboplastin time, d-dimers, factor VIII coagulant activity, plasma von Willebrand factor (VWF) antigen and VWF ristocetin cofactor (RC)). We compared coagulation profiles in samples from children identified with PCC (at least one, or three or more symptoms, which could not be explained by an alternative diagnosis, at the 8- and 12-week follow-up assessment using the pediatric Long Covid International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) survey. Seventy-five children were enrolled, 49.3% were females, the median age was 10.2 (IQR 4.9) years. Forty-six (61%) of the children had at least one persisting symptom at the eight weeks post-onset, (PCC8); 39/75 (52%) had persistent symptoms for more than 12 weeks (PCC12) and 15/75(32%) had at least three persisting symptoms (PCC ≥ 3) at 12 weeks. Children with PCC presented more frequently with abnormal D-Dimer levels above the reference range compared to children that had fully recovered at the 8–12 weeks (39.1% vs. 17.2%, p = 0.04), and 12 week follow up or more (41% vs. 17.2%, p = 0.05), and in children with three or more symptoms at 12 weeks follow up compared to those that had recovered (64.3% vs. 22.2%, p = 0.002). For the other coagulation profiles, there were abnormal values detected for VWF, FVIII, RC and Fibrinogen but no significant differences between children with PCC compared to controls. Although the majority of children in our cohort showed coagulation profile within or close to normal ranges, we found that a higher proportion of children with PCC, and specifically those with a more severe spectrum characterized with three or more persisting symptoms, had abnormal D-dimer levels compared to other children that fully recovered from an acute SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-9626616
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96266162022-11-02 Extended coagulation profile of children with Long Covid: a prospective study Di Gennaro, Leonardo Valentini, Piero Sorrentino, Silvia Ferretti, Maria Antonietta De Candia, Erica Basso, Maria Lancellotti, Stefano De Cristofaro, Raimondo De Rose, Cristina Mariani, Francesco Morello, Rosa Lazzareschi, Ilaria Sigfrid, Louise Munblit, Daniel Buonsenso, Danilo Sci Rep Article Emerging data suggests that endotheliopathy changes can be associated with post covid condition (PCC) in adults. Research on the matter in children is lacking. We analyzed an extended coagulation profile including biomarkers of endothelial damage in children with PCC and compared it with a control group of children that fully recovered post- SARS-CoV-2 infection. A case-control study enrolling children below 18 years of age with previous microbiologically confirmed SARS-CoV-2 infection in a pediatric post-covid unit in Italy ≥ 8 weeks after the initial infection. Samples were taken at 8 and 12 weeks after the SARS-CoV-2 diagnosis and analyzed for coagulation profiling (fibrinogen, prothrombin time, international normalized ratio, activated partial thromboplastin time, d-dimers, factor VIII coagulant activity, plasma von Willebrand factor (VWF) antigen and VWF ristocetin cofactor (RC)). We compared coagulation profiles in samples from children identified with PCC (at least one, or three or more symptoms, which could not be explained by an alternative diagnosis, at the 8- and 12-week follow-up assessment using the pediatric Long Covid International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) survey. Seventy-five children were enrolled, 49.3% were females, the median age was 10.2 (IQR 4.9) years. Forty-six (61%) of the children had at least one persisting symptom at the eight weeks post-onset, (PCC8); 39/75 (52%) had persistent symptoms for more than 12 weeks (PCC12) and 15/75(32%) had at least three persisting symptoms (PCC ≥ 3) at 12 weeks. Children with PCC presented more frequently with abnormal D-Dimer levels above the reference range compared to children that had fully recovered at the 8–12 weeks (39.1% vs. 17.2%, p = 0.04), and 12 week follow up or more (41% vs. 17.2%, p = 0.05), and in children with three or more symptoms at 12 weeks follow up compared to those that had recovered (64.3% vs. 22.2%, p = 0.002). For the other coagulation profiles, there were abnormal values detected for VWF, FVIII, RC and Fibrinogen but no significant differences between children with PCC compared to controls. Although the majority of children in our cohort showed coagulation profile within or close to normal ranges, we found that a higher proportion of children with PCC, and specifically those with a more severe spectrum characterized with three or more persisting symptoms, had abnormal D-dimer levels compared to other children that fully recovered from an acute SARS-CoV-2 infection. Nature Publishing Group UK 2022-11-01 /pmc/articles/PMC9626616/ /pubmed/36319840 http://dx.doi.org/10.1038/s41598-022-23168-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Di Gennaro, Leonardo
Valentini, Piero
Sorrentino, Silvia
Ferretti, Maria Antonietta
De Candia, Erica
Basso, Maria
Lancellotti, Stefano
De Cristofaro, Raimondo
De Rose, Cristina
Mariani, Francesco
Morello, Rosa
Lazzareschi, Ilaria
Sigfrid, Louise
Munblit, Daniel
Buonsenso, Danilo
Extended coagulation profile of children with Long Covid: a prospective study
title Extended coagulation profile of children with Long Covid: a prospective study
title_full Extended coagulation profile of children with Long Covid: a prospective study
title_fullStr Extended coagulation profile of children with Long Covid: a prospective study
title_full_unstemmed Extended coagulation profile of children with Long Covid: a prospective study
title_short Extended coagulation profile of children with Long Covid: a prospective study
title_sort extended coagulation profile of children with long covid: a prospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626616/
https://www.ncbi.nlm.nih.gov/pubmed/36319840
http://dx.doi.org/10.1038/s41598-022-23168-y
work_keys_str_mv AT digennaroleonardo extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT valentinipiero extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT sorrentinosilvia extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT ferrettimariaantonietta extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT decandiaerica extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT bassomaria extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT lancellottistefano extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT decristofaroraimondo extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT derosecristina extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT marianifrancesco extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT morellorosa extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT lazzareschiilaria extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT sigfridlouise extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT munblitdaniel extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy
AT buonsensodanilo extendedcoagulationprofileofchildrenwithlongcovidaprospectivestudy